IntegraGen SA

ALINT.PA·Paris·Healthcare
Compare
0.07500.0000 (0.00%)today
As of Oct 30, 10:53 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.0750
Open0.0652
Day range0.06500.0750
52-week range0.01300.3610
Off day high0.00%
Off 52-week high−79.22%
Volume11.77K
Avg. volume (3M)66.17K
Market cap496.55K
EPS (TTM)-0.0200
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.61
Shares outstanding6.61M
Short interest—
Earnings dateApr 29, 2025
Analyst target—
Profit margin−53.06%

Against its peers

Compare in full ›
ALINT.PA VRAX AIM IMNN CDIO CSBR
Market cap 496.55K 1.61M 6.42M 5.09M 4.87M 67.23M
P/E (TTM) — — — — — —
Forward P/E — -0.2 -0.4 -0.5 -6.6 48.3
Price/book -0.5 0.1 0.6 2.2 0.7 17.3
Dividend yield — — — — — —
1-year change −47.00% −90.40% −90.12% −77.02% −59.08% −29.80%
Today 0.00% +13.21% +0.19% +0.78% +2.81% 0.00%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ALINT.PA news ›
GenomeWeb·

ABL Texcell Acquires IntegraGen

France’s ABL Texcell Acquires Precision Oncology Developer IntegraGen GenomeWeb France’s ABL Texcell Acquires Precision Oncology Developer IntegraGen

From the 4Search news index, newest first.

In the news

1mentions in 30 days
1with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance